Navigation Links
ROBODOC(R) Emerges as a Curexo Technology Company at Upcoming Orthopaedic Surgeons Conference in San Francisco
Date:2/28/2008

SACRAMENTO, Calif., Feb. 28 /PRNewswire/ -- ROBODOC, a Curexo Technology Company, and newly formed division of Curexo, Inc., announced today that they will be exhibiting at the upcoming American Association of Orthopaedic Surgeons Annual Conference being held at the Moscone Center in San Francisco, March 5th through the 7th; Hall D, Booth #4470.

"Because the ROBODOC Product brand has a strong worldwide recognition, Curexo Inc. has decided to name the company ROBODOC, a Curexo Technology Company," said Dr. Ramesh Trivedi, President and CEO.

"We are looking forward to attending the AAOS meeting in San Francisco to present the only fully automated Robotics technology to the US orthopaedic community even though, it has been available for many years to the surgeons throughout the world. Combining our pioneering work with many years of experience of routinely performing joint replacement surgeries overseas and the strong support of our new partner, Curexo Inc., strongly positions us to offer a unique solution for the current and future challenges in orthopaedic surgery. Together with our partner Curexo, Inc. we have developed strong technical and marketing initiatives for the future, and are prepared to move forward into the US Market," added Dr. Trivedi.

About ROBODOC

ROBODOC, develops, manufacturers, and markets a fully automated surgical robotic system for orthopaedic surgery. The system includes two components; ORTHODOC, a computer workstation equipped with proprietary software for preoperative surgical planning, and ROBODOC, a computer-controlled surgical robot for use in hip and knee replacement as well as other orthopaedic surgeries. ROBODOC made medical history in 1992 by assisting in a Total Hip Arthroplasty (THA) procedure. Since that time, the ROBODOC system has been used in over 20,000 surgical procedures to assist the surgeons around the world. The ROBODOC Surgical Assistance System is currently in its final stage of review and clearance by the FDA.

ROBODOC(R) and ORTHODOC(R) are registered trade marks of Curexo Technology Corporation
1433 N. Market Blvd., Suite 1, Sacramento, CA 95834

http://www.robodoc.com

Contact: Dr. R.C. Trivedi

President & CEO

ROBODOC(R)

A Curexo Technology Company

916 285 9943 x 527

or

Ms. Sheila Shah

Marketing Communications

ROBODOC(R)

A Curexo Technology Company

916 285 9943 X 510

press@robodoc.com


'/>"/>
SOURCE ROBODOC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CT Laser Mammography Technology to be Featured at Interdisciplinary Breast Cancer Conference
2. Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production
3. Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
4. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
5. Attagenes Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods
6. Newly Published EPA RCRA Method 6800 Supports AIT Technology
7. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
8. Malaysia Genome Institute Advances Bioinformatics Research Using SGI Technology
9. West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase
10. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
11. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... In anticipation of ... lumbar disc production, company President, Jake Lubinski will be traveling to Germany on ... disc in Cologne and Karlsruhe to discuss the benefits of a viscoelastic total ...
(Date:12/5/2016)... WOODCLIFF LAKE, N.J. , Dec. 5, 2016 ... its Phase 3 open-label two-year study of rufinamide, ... of the American Epilepsy Society (AES) held from ... . Analysis of final two-year safety, tolerability and ... therapy with rufinamide experienced similar safety and tolerability ...
(Date:12/4/2016)... DIEGO , Dec. 3, 2016  In five ... of Hematology (ASH) Annual Meeting and Exposition in ... biomedical engineering methods to improve the delivery of life-saving ... These new methods are designed to carry therapies directly ... needed most, which could provide a substantial advantage over ...
(Date:12/2/2016)... Amgen (NASDAQ: AMGN ) and Allergan ... of a Marketing Authorization Application (MAA) to the European Medicines ... ® (bevacizumab). The companies believe this submission is the ... "The submission of ABP 215 to the EMA is ... portfolio," said Sean E. Harper , M.D., executive vice ...
Breaking Biology Technology:
(Date:11/17/2016)... , Nov. 17, 2016  AIC announces that it has just released a new ... that require high-performance scale-out plus high speed data transfer storage solutions. Photo ... ... ... Setting up a high performance computing ...
(Date:11/15/2016)... Nov 15, 2016 Research and Markets has ... to 2021" report to their offering. ... ... Billion by 2021 from USD 6.21 Billion in 2016, growing at ... Growth of the bioinformatics market is driven by the growing demand ...
(Date:6/27/2016)... 27, 2016 Research and Markets has announced ... report to their offering. ... to grow at a CAGR of 12.28% during the ... on an in-depth market analysis with inputs from industry experts. The ... coming years. The report also includes a discussion of the key ...
Breaking Biology News(10 mins):